Your browser doesn't support javascript.
loading
Ischemic stroke and purpuric dermatitis as COVID-19-related complications in a peritoneal dialysis patient.
de Lorenzo Alvarez, Alberto; Revilla, Ángela; Corbalán, Teresa; Villar, Ana; Espinel, Laura; Martins, Judith; Cubas, Alfonso.
Afiliação
  • de Lorenzo Alvarez A; Department of Nephrology, Hospital Universitario de Getafe, Carr. Madrid-Toledo, Km 12,500, Getafe, 28905, Madrid, Spain. albertodelorenzoalvarez@gmail.com.
  • Revilla Á; Primary Care Center El Greco, Getafe, Madrid, Spain.
  • Corbalán T; Department of Radiology, Hospital Universitario de Getafe, Madrid, Spain.
  • Villar A; Department of Pathology, Hospital Universitario de Getafe, Madrid, Spain.
  • Espinel L; Department of Nephrology, Hospital Universitario de Getafe, Carr. Madrid-Toledo, Km 12,500, Getafe, 28905, Madrid, Spain.
  • Martins J; Department of Nephrology, Hospital Universitario de Getafe, Carr. Madrid-Toledo, Km 12,500, Getafe, 28905, Madrid, Spain.
  • Cubas A; Department of Nephrology, Hospital Universitario de Getafe, Carr. Madrid-Toledo, Km 12,500, Getafe, 28905, Madrid, Spain.
CEN Case Rep ; 10(2): 250-254, 2021 May.
Article em En | MEDLINE | ID: mdl-33205335
Patients on dialysis may have an elevated risk of severe coronavirus disease 2019 (COVID-19) and its complications due to their high prevalence of comorbidities. Here we describe the case of an 80-year-old male undergoing peritoneal dialysis with a moderate SARS-CoV-2 infection who developed a purpuric dermatitis and ischemic stroke after successful recovery from his bilateral pneumonia. Erythemato-papular lesions affecting trunk and lower limbs appeared 17 days after the onset of SARS-CoV-2 symptoms. These kind of lesions are an infrequent cutaneous manifestation of COVID-19. The pathology revealed a moderate purpuric dermatitis affecting superficial dermis and corticoesteroids were prescribed achieving complete resolution. Arterial thrombosis affecting cerebellar vermis emerged 30 days after the onset of COVID-19 symptoms. It occurred 5 days after withdrawal of antithrombotic prophylaxis that the patient received from his admission until 2 weeks after discharge. He completely recovered from his paresis and continued on his regular antiaggregation therapy. This is the first case report published of a patient with PD with such COVID-19-related complications. More experience is needed to determine the appropriate length of antithrombotic prophylaxis especially in high-risk individuals.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Diálise Peritoneal / Dermatite / AVC Isquêmico / COVID-19 / Falência Renal Crônica Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Aged80 / Humans / Male Idioma: En Revista: CEN Case Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Diálise Peritoneal / Dermatite / AVC Isquêmico / COVID-19 / Falência Renal Crônica Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Aged80 / Humans / Male Idioma: En Revista: CEN Case Rep Ano de publicação: 2021 Tipo de documento: Article